Critical Appraisal Bias - Blinding/Follow Up Flashcards
Why do we blind Patients
To prevent placebo effect
Why do we blind Clinicians
To prevent cointerventions
- Additional procedures to sway the data
Why do we blind Data Collectors
To prevent bias in collection
Why do we blind Outcome Adjudicators
To prevent bias in decisions regarding outcomes
- When deciding who has what outcomes
Why do we blind Data Analysts
To avoid bias in decisions regarding data analysts
Open Label Study
No blinding
- Clinicians and Patients no which intervention they have
PROBE Design
Patient and Clinician can not be blinded
Can blind Outcome Adjudicators
How to control placebo
Blinding
Make outcomes less subjective
Ask patients at the end if they think they received
Contamination
Patient receives treatment from the other group
Why is loss of follow up important
If the patient is lost to follow up then the study wont be able to record their events and outcomes
Loss To Follow Up
- Rule of Thumb
5% Rule
- If 5% or below then risk of bias is low and we can tolerate the
20% Rule
- If 20% or higher than risk of bias is high and we can not trust the data
Loss of Follow Up is between 5% and 20%
Assume worst case scenario
- The minimal effect the intervention can have
Even in the worst case there is still benefit
Patients lost in follow up vs patients remaining
Both groups have different prognosis
- Usually the patients lost to follow up either are much sicker or much healthier
Alternative to 5% and 20% rule
Assume worst case scenario
So for an experimental treatment that reduces a bad event
- Assume the patient’s outcome was the bad effect
How to deal with missing data
- Single Imputation
- Carry last observable outcome forward
- Replace with average value of all participants
- Use regression model to predict missing value based on trends